Fort Worth, TEXAS2 Active Studies

Geographic Atrophy Clinical Trials in Fort Worth, TEXAS

Find 2 actively recruiting geographic atrophy clinical trials in Fort Worth, TEXAS. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
580
Enrolling

Recruiting Geographic Atrophy Studies in Fort Worth

About Geographic Atrophy Clinical Trials in Fort Worth

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 2 geographic atrophy clinical trials recruiting participants in Fort Worth, TEXAS. These studies are seeking a combined 580 participants. Research is being sponsored by Astellas Pharma Global Development, Inc., Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Fort Worth — FAQ

Are there geographic atrophy clinical trials in Fort Worth?

Yes, there are 2 geographic atrophy clinical trials currently recruiting in Fort Worth, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Worth?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Worth research site will contact you about next steps.

Are clinical trials in Fort Worth free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Worth studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 2 active trials in Fort Worth are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov